PTGX Earnings

Quarterly EPS
$-0.54
Q3 2024
$2.11
Q4 2024
$-0.19
Q1 2025
$-0.55
Q2 2025
$-0.62
Q3 2025
$-0.69
Q4 2025
$0.06
Q1 2026
$2.47
Q2 2026
Latest Revenue213.5M
Latest Net Income162.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$2.47213.5M162.8M+3,749.2%+549.1%
Q1 2026$0.0656.4M3.8M+99.0%+131.6%
Q4 2025-$0.697.4M-44384000-95.6%-132.7%
Q3 2025-$0.624.7M-39339000+0.8%-14.8%
Q2 2025-$0.555.5M-34771000+33.1%-10.0%
Q1 2025-$0.1928.3M-11655000-88.9%-105.6%
Q4 2024$2.11170.6M131.7M+184.4%+368.9%
Q3 2024-$0.544.7M-33210000+6.9%
Q2 2024-$0.504.2M-30616000
Q1 2024$3.41255.0M207.3M
Q4 2023$0.4560.0M27.3M
Q3 2023-$0.580-34105000
Protagonist Therapeutics (PTGX) — Earnings